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The present study is the first of a  series designed to use hypersensitivity of 
the immediate type to diphtheria  toxin or toxoid as a  model for the study of 
the  hay-fever type  of  allergy.  The  use  of  the  toxin-antitoxin  system in  the 
experimental study  of allergy possesses several distinct  advantages over less 
well  characterized  systems  such  as  are  encountered  in  patients sensitive to 
pollens, grasses, etc.  In the first place, diphtheria  toxin and toxoid are avail- 
able in a  high state of purity and are reasonably well characterized proteins. 
Secondly, it is possible to measure by means of the sensitive rabbit intracuta- 
neous test both toxin and antitoxin with considerable accuracy even when they 
are present in very low concentration.  Finally, it has been demonstrated that 
administration of a  single dose of purified diphtheria toxoid into Schick-nega- 
tive adults is frequently followed by a rapid and high antitoxin response. Quan- 
titative studies  (1) have shown that no other antibody is formed in apprecia- 
able  amount  and  therefore  the  toxin-antitoxin  reaction  in  human  beings 
immunized in this way closely approximates a  single antigen-antibody system. 
Prausnitz  and Kustner in  1921 (2) first demonstrated in an allergic  individual a 
serum factor which was capable of causing local sensitivity of the wheal and erythema 
type in the skin of normal human subjects.  (Sensitivity to fish was passively trans- 
ferred in the original experiments.) Prausnitz and Kustner showed that the reaction 
was  highly  specific  but  they  were  unable  to  demonstrate  either  precipitating  or 
complement-fixing antibodies in the patient's serum, nor was it capable of passively 
sensitizing guinea pigs to anaphylactic shock. Moreover, they were unable to demon- 
strate by means of skin tests neutralization of the allergen in extracts of fish by the 
patient's serum. Most of the original observations were subsequently confirmed  and 
extended to include passive transfer of sensitivity to a variety of antigenic materials. 
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Coca and Grove (3) later found the allergic factor, termed by them atopic reagin, 
in the serum of all subjects with hay-fever or asthma in whom a positive skin test 
could be elicited.  Not only were Coca and  Grove unable to sensitize guinea pigs to 
anaphylactic shock with the allergic factor, but even tests using the sensitive Schultz- 
Dale method of uterine contraction were negative. The same authors showed that the 
serum factor could be neutralized by the homologous antigen since injection of test 
tube mixtures of antigen and serum failed to sensitize the skin. In other words, al- 
though injection of the test tube mixture caused an immediate wheal and erythema 
reaction, no reaction could be elicited  when the site was challenged 24 hours later 
provided sufficient antigen was added to combine with all the reagin. On the other 
hand neutralization of the antigen or (allergen)  by reagin could not be demonstrated 
at skin sites.  Coca and Grove also showed that local passive sensitization persisted for 
4 weeks or longer and that the skin-sensitizing capacity of atopic reagin was consider- 
ably diminished by heating for 1/2 hour at 56°C. 
The method most frequently used in treatment of hay-fever patients  consists of 
repeated  and  increasing  subcutaneous  doses  of allergen.  Thus,  treatment  may be 
regarded as specific immunization. Levine and Coca (4) showed that treatment may 
result in an increased titer of atopic reagin in the patient's serum. They introduced 
two methods of quantitative determination of reagin. In the first, progressive serum 
dilutions were placed in skin sites of a normal recipient and followed by injection 24 
hours later of a fixed quantity of the corresponding antigen into the sensitized areas. 
The second depended on the reaction produced by injecting progressively increasing 
amounts of antigen into areas of normal skin previously sensitized  by injection of 
serum in constant amounts. Attempts were made later by Lippard and Schmidt (5) 
to  further  quantitate  methods  for  titrating  the  passive  transfer  antibody.  They 
determined the amount of antigen (in terms of mg.-N) necessary to neutralize avail- 
able antibody in a given amount of serum. The procedure involved mixture of various 
dilutions of antigen with constant amounts of serum in vitro, the intracutaneous in- 
jection of resultant mixtures, and a subsequent intramuscular challenge injection of 
antigen 1 to 3 days later. There was close correlation between the titers obtained by 
serum dilution and neutralization methods. 
A  new concept was introduced when Cooke et al.  (6)  demonstrated that sera of 
treated  patients  occasionally contained  a  specific  protective  substance  which they 
termed blocking or inhibiting antibody. The presence of blocking antibody was thought 
to be correlated with  clinical  benefits  observed in patients  following treatment  by 
means of specific immunization. Cooke et al. (7) later found that blocking antibody was 
also formed by normal individuals injected with pollen extracts. 
The work of Loveless (8)  served to further differentiate blocking antibody from 
atopic reagin. She showed that blocking antibody differs  from reagin in that it dis- 
appears rapidly from injected skin sites.  In contrast to reagin, blocking antibody re- 
tains its activity after prolonged heating at 56°C. Loveless has used the latter property 
to  eliminate  heat-labile  reagin  from  the  serum  of treated  hay-fever patients  and 
permit the separate demonstration of thermostable blocking antibody. However, her 
experiments did not rule out the possibility that heated reagin may retain its capacity 
to combine with allergen while losing its wheal- and erythema-producing capacity. 
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that heating Ascaris-sensitizing  serum for as long as 24 hours did  not remove its 
neutralizing power. Similar findings were also reported by Lippard and Schmidt (10) 
with heated serum of pollen-sensitive patients. 
Loveless (11) showed  that high titers of thermostable blocking antibody developed 
in 3 "normal" subjects who received repeated injections of ragweed pollen extracts. 
Only one of the subjects developed skin sensitivity to ragweed pollen.  She was unable 
to demonstrate precipitins in the serum from any of the 3 individuals. 
Recent studies with relatively pure antigens have tended to confirm earlier investi- 
gations which demonstrated antibodies of varying reactivities against hay-fever  pollen. 
Lowell (12) has presented evidence that an immune mechanism plays a role in some 
cases of insulin resistance. He found a high state of resistance to crystalline beef and 
pork  insulin  in  a  patient  who  still  responded  to  human  insulin  preparations. 
The resistance was observed to develop during periods in which beef or pork insulin 
was administered and to disappear when insulin  was withheld.  The patient was also 
allergic to beef and pork insulin.  Injections of insulin caused swelling and generalized 
urticaria and serum specimens were shown to contain skin-sensitizing  antibody. Of 
significance  in this patient was the fact that the degree of resistance and hypersen- 
sitivity varied independently. 
Sherman et al.  (13) have shown that rabbits immunized by subcutaneous injection 
of recrystallized, alum-precipitated ovalbumin formed both precipitating antibody and 
non-precipitating antibody. Only the latter was capable of sensitizing  human skin. 
Addition of equivalent amounts of antigen all at once to this serum resulted in copre- 
cipitation of skin-sensitizing  antibody. However, the latter remained in the supernatant 
when the serum was absorbed by repeated small amounts of antigen. It was of interest 
that animals similarly injected with fluid ovalbumin formed only precipitating anti- 
body. In sera which possessed both types of antibody, the amounts of skin-sensitizing 
antibody present bore no relation to the precipitin content and were dependent on 
the amounts of so-called "univalent" or "incomplete" (14) antibody present. 
The stimulus for the present investigations began when Dr. H. S. Lawrence 
drew to our attention the case of a 6 year old boy with a personal and familial 
history  of allergy,  who  was  brought  into  hospital  in  severe asthmatic  crisis 
precipitated within a  few minutes following a  routine  "booster" dose of diph- 
theria toxoid administered by his school physician. Subsequently, minute doses 
of purified  diphtheria  toxoid given intracutaneously produced  marked wheal 
and  erythema reactions  with long spidery pseudopodia  at  the  injection  site. 
As little as 0.001  /zg. toxoid caused a pronounced skin reaction. Moreover, the 
specific sensitivity to toxoid could be passively transferred to normal skin sites 
with 0.001  cc. of serum or less. Serum drawn 2 days after admission showed an 
antitoxin titer of 50 units per cc. by rabbit skin test but contained no precipi- 
tating antitoxin whatever (15). This behavior was quite unusual since in pre- 
vious studies the sera of a large series of normal subjects hyperimmunized with 
purified toxoid had all shown good precipitin reactions when 5 units/cc, or more 
of antitoxin were present (1, 16). 
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of  individuals  whose  serum  contained  a  high  titer  of  non-precipitating  anti- 
toxin.  It will be shown that  such non-precipitating antitoxin possesses proper- 
ties characteristic  of  atopic  reagin. 
Materials and Methods 
Schick Test Materia/1.--Highly purified diphtheria toxin diluted in buffered heated human 
serum albumin (17)  to 0.2 guinea pig ~.r..D. per cc. was used in the Schick test. Highly puri- 
fied toxoid containing 0.08 Lf per cc. was used as the control. The volume injected intraderm- 
ally was 0.1 cc. 
TABLE I 
Grading 0 ¢ Immediate Reactions to Schick Test 







20 to 25 
15 to 20 
10 to 15 
Intensity  Wheal 
++++  Over 15 
+++  10-15 
++  5-10 
++  O-5 
Usually present 
Present or absent 
Absent 
Absent 
TABLE  II 
Immediate Reaaion to Schick Test in 131 Medi,  cal Students 
Strength of immediate reaction to Schick  No. claiming personal or  No. claiming no personal or 
















Total ........................  59  72 
Reactions to the Schick Test.--Immediate reactions were read at the Schick control site 15 
to 30 minutes after performing the Schick test. The size of the wheal and of the erythema were 
both measured and the presence of pseudopodia, pmritis, and color intensity noted. On the 
basis of these criteria, reactions were rated as negative, +,  ++,  ++-b,  and q-q-++  (see 
Table I). 
In all subjects additional skin sites were injected with 0.1 cc.  buffered human albumin 
(Schick diluent)  as  a  control. The volunteers also received simultaneously intracutaneous 
injections of old tuberculin (1:1000) and this served as a further control. Equally strong im- 
mediate reactions against both toxoid and albumin diluent are arbitrarily classified in Table 
II as negatives. Thus, in one group of individuals with a personal or familial history of allergy, 
11 of 24 (46 per cent) negative reactors fell in this category, and 12 of 67 (18 per cent) of the 
non-allergic group were likewise classified as negative because they reacted in this manner. 
1 The authors are indebted to Dr. J. A. McComb and L. Levine of the Massachusetts Anti- 
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The Schick test  was read again at 48 hours and individuals  who showed cutaneous reac- 
tions  of  the delayed type  or  who were Schick-positive  were  not  studied  further. 
Allergi,  Histories.--All  persons were questioned in regard to allergic  history.  Included in 
the survey were questions  related  to personal sensitivities  of the immediate wheal and cry- 
thema variety and treatment given,  if any. Individuals with contact or delayed types of 
dermatitis  were not  includcd  in  this  category.  The same questions  were  asked concerning the 
existence  of allergies  in relatives,  including  parents,  grandparents, brothers,  sisters,  uncles, 
aunts,  and first  cousins. 
Immunization.--Subjects  who were Schick-negative  but  who did  not show a delayed reac- 
tion  to  Schick control  toxoid  at  48  hours  were  given at this  time  a single  injection  of  purified 
diphtheria toxoid subcutaneously. The dose was 37.5 Lf for fluid  toxoid  and 60 Lf when 
purified  toxoid  adsorbed  on  alumina cream (18)  was used.  2 subjects  received  only  0.75  Lf  of 
fluid  toxoid  and 2 received  200 Lf adsorbed on alumina cream. 
Medical and dcntal students constituted a  large proportion of the immunized  group. 
They  were  divided  into  two  categories.  The first  was  a  normal  group  which  gave  no  immediate 
skin reaction  against  Schick toxoid  and no  personal  or  familial  history  of  allergy.  The second 
group  comprised  persons  with  positive  immediate  skin  reactions  against  Schick  toxoid  and  a  per- 
sonal allergic  history.  Additional selected  patients  in the allergy  clinic  and in hospital  were 
also  hyperimmunized. The criteria  for  selection  were the same as those outlined  above. The 
desired  minimal qualification  for the allergic  group was a strong  personal history  of  allergy. 
Preimmunization bleedings  were taken at the time the Schick tests  were given.  The booster 
dose of toxoid  was given 48 hours later.  Postinmaunization bleedings  were usually  drawn on 
the 10th or 14th day and in certain  cases  at intervals  thereafter.  Serum was removed and 
stored  in  small glass  tubes at -30°C until  used. 
In Vivo  Antitoxin  T/ten--The rabbit  intracutancous test  was used,  following  the technic 
of  Fraser (19).  In  all  cases  unknowns were  compared with  a simultaneous titration  carried  out 
with standard antitoxin  obtained from the National Institutes  of Health. Dilutions were 
spaced  in  such  a manner that  the  titrations  are  generally  accurate  to  within i0  to 15  per  cent. 
Removal of  Complement.--Complement was removed from human antitoxic  sera  prior  to 
carrying out quantitative  precipitin  tests.  An amount of anti-type  III  pneumococcal rabbit 
serum sufficient  to  yield  S0/~g.  spedfically  precipitable  nitrogen  upon addition  of  an  appropri- 
ate  amount of  SIII  was added per  ml. of  human serum. After standing  in  the  cold  for  4 days, 
the  specific  precipitate  was removed by centrifugation. 
Quantitative  Preclpitin  Reaction.--The  test  was  carried  out  by  adding an  appropriate 
amount of antitoxin to varying amounts of toxin. On the basis of titers obtained in the rabbit 
skin tests, sera were diluted or added in amounts so that about 30 units was present in each 
tube. The number of tubes set up for a  given titration varied somewhat. As a  rule, five to 
eight points were selected along a calculated theoretical curve, and toxin was added in incre- 
ments of 5 Lf up to and slightly over the calculated point of equivalence assuming that 1 Lf 
1 antitoxic unit.  The purified  toxin used contained 2480 Lf/ce., and 1 Lf was equivalent 
to 0.46 t~g. specifically preeipitable N. 
Dilutions of toxin were made in borate-NaCl buffer pH 7.4 containing 200 ~g. gelatin per 
ml. to prevent surface denaturation. All tubes were adjusted to the same total volume (3 cc.) 
with borate buffer. Following the addition of antigen to antiserum, the mixture was agitated 
briefly, incubated at 37°C.  for 1 hour and placed in the cold for 10 to 14 days. This precau- 
tion is usually unnecessary in the case of sera giving normal in vivo/in vitro ratios and precipi- 
tation in such instances is complete within 24 hours in contrast to human antipneumoeoccal 
sera  (21)  which precipitate slowly. However, antitoxins with high in vivo/in vitro ratios also 
precipitate slowly and were therefore allowed to remain in the cold for a  protracted period. 
Merthiolate was added to concentration of 1:10,000. This was done after comparative titra- 
tions performed with and without the addition of merthiolate had demonstrated that this 
substance possessed no inhibitory effect upon precipitability.  After centrifugation,  the su- 
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The precipitates  were broken up and washed three times with cold saline. Nitrogen was 
determined  by Markham's (20) modification of the micro-Kjeldahl method,  using a  Scho- 
lander burette. 
The assay of supernatants  was performed by use of the intracutaneous  rabbit and guinea 
pig tests. 
RESULTS 
Relationship  between Skin Sensitivity  and Allergic History.--Immediate  skin 
reactions of the wheal and erythema type were surprisingly frequent among a 
group of 131 medical students Schick-tested with purified diphtheria toxin using 
purified  toxoid as control. As can be seen from Table II, 40 immediate reactions 
were observed, an incidence of 30.5 per cent. The incidence of such reactions 
was twice as high among the Schick-negative individuals as compared with the 
Schick-positives  (Table III). Moreover, 4  of the 6  Schick-positive individuals 
TABLE III 
Immediate Reaction to Schick Test in 35 Schick-Positive Medical Students 
Strength of immediate reaction to Schick  No. claiming personal or  No. claiming no personal or 











Total ........................  13  22 
who showed an immediate wheal and erythema reaction had become Schick- 
negative when retested 1 month later, indicating the presence of some antitoxin 
at the time the first test was carried out. 35 of the 40 (87.5 per cent) showing 
immediate  reactions  gave  either  a  personal  or  familial  history  of allergy or 
both. It is significant that all the eleven subjects whose skin reactions were rated 
as 4-4-  (i.e., the most severe)  were both Schick-negative and gave a  history of 
allergy.  It seems worth while to present  brief histories obtained from each of 
these  11  subjects: 
1.  Fe  Personal historywhay-fever 10 years. 
Familymgrandmother  has hay-fever. 
2.  Ro  Personal history--O. 
Family--mother allergic to numerous foods. 
3.  Sa  Personal--vasomotor  rhinitis. 
Family--father has hay-fever. 
4.  Sch  Personal--allergic  to dusts,  gets  attacks of sneezing of unknown  cause  every 
spring. 
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5.  Ch  Personal---sensitive  to timothy and egg white, has hay-fever. 
Family--mother has hay-fever. 
6.  Ha  Personal--hay-fever for a number of years. 
Family--no allergic history elicited. 
7.  Kr  Personal--hay-fever 2 years (ragweed); treated. 
Family--lst cousin has hay-fever. 
8.  La  Personal--hay-fever  21  years,  treated;  asthmatic  attacks,  allergic to grasses, 
trees, ragweed. 
Family--many members with hay-fever and other allergies. 
9.  Lau  Personal--hay-fever 5 years (ragweed); treated. 
Family--2 cousins with hay-fever. 
I0. Ne Personal--allergic to dusts and  a  variety  of vegetables, vasomotor rhinitis  of 
long standing. 
Family--no allergic history elicited. 
11.  Bi  Personal--allergic to cat hair and other furs, attacks of idiopathic purpura. 
Family--mother and brother have hay-fever. 
7  of 9  Schick-negative patients  tested  in  allergy clinics showed  the  ~vheal 
and erythema reaction at the Schick control site. 
Immediate  Reactions  to  Toxoid  Following  Immunization.--Regardless  of 
whether or not immediate skin reactions were observed at the time of initial 
Schick  test,  almost all  Schick-negative individuals  developed some degree of 
skin sensitivity to purified toxoid following a  "booster" dose of toxoid  (Table 
IV). Thus 34  of 39 persons tested  1 month  after immunization showed skin 
reactivity of the immediate type. This was independent  of whether fluid- or 
alum-precipitated toxoid was used as immunizing agent. All but one of the 5 
who failed to react showed less than  10 units circulating antitoxin per cc.  19 
of the total group of 39 showed no skin reaction prior to immunization. 
It is of interest that some of the subjects who showed the greatest degree of 
skin  sensitivity following immunization  were  those  who gave no  personal  or 
familial history of allergy and who showed no immediate reaction at the time 
of the first Schick test. While most of the more severe skin reactions following 
immunization occurred among the group with allergic histories, the correlation 
was considerably less striking than that shown in Table II. 
Non-Precipitating  Diphtheria Antitoxin.--The  evidence for presence or ab- 
sence of non-precipitating antitoxin in sera was based on whether a discrepancy 
was observed between the unitage determined by the rabbit skin test (in vivo) 
and the quantitative precipitin test (in vitro).  The number of units  as deter- 
mined by the precipitin reaction was calculated by dividing the antitoxin nitro- 
gen found at the point of maximal precipitation by 2.5.  In a previous study (1) 
of sera  from  12  hyperimmunized  "normal"  human  subjects  close  to  2.5  /ag. 
nitrogen  was precipitated per unit  of antitoxin.  In  order  to  obtain maximal 
precipitation it was necessary to add only 0.75 4- 15 per cent Lf toxin for each 
unit  of antitoxin  found  by rabbit  skin  test.  This  deviation  from unity  was 
shown to be dependent on the in vivo/in vitro ratio of the horse serum used as TABLE  IV 
Immediate Skin Reaction, Rabbit Skin Titer, and Quantitative Precipitin  Titer in 39 






























60 Lf alum 
200 Lf alum 
37.5 Lf fluid 
200 Lf alum 
37.5 Lf fluid 
37.5 Lf fluid 
60 Lf alum 
60 Lf alum 
37.5 Lf alum 
60 Lf alum 
37.5 Lf fluid 
37.5 Lf fluid 
37.5 Lf fluid 
60 Lf alum 
37.5 Lf fluid 
37.5 Lf fluid 
37.5 Lf fluid 
60 Lf alum 
60 Lf alum 
60 Lf alum 
60 Lf alum 
37.5 Lf fluid 
37.5 Lf fluid 
24. He  0.75 
25. Si  0.75 
26. Ap  37.5 
27. Do  37.5 
28. Fe  37.5 
29. Ja  37.5 
30. Ra  37.5 
31. We  37.5 
32. Ch  37.5 
33. Le  37.5 
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* Rabbit intracutaneous test. 
Figures in column  6  refer to  units calculated  from  specifically precipitable antitoxin 
nitrogen. (+)  designates sera which produced a precipitate with an added amount of toxin 
at the equivalence point calculated from the rabbit skin test--a saline control tube was run 
with each serum tested. If the precipitate appeared of sufficient bulk, as judged by inspection, 
the in vivo/in vitro ratio was considered normal and is marked N  in column 7. 
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a standard in carrying out the in vivo.~itrations  in the rabbit skin. In the present 
study we have encountered very much larger deviations in certain sera which 
cannot be accounted for in this way. Thus 12 of 30 sera from hyperimmunized 
subjects  showed marked  discrepancies  with in  vivo/in  vitro  ratios  of  1.8  or 
greater. Moreover, sera from 3 persons failed to  precipitate  at  all with toxin 
despite the presence of 20 or more units of antitoxin per cc. by in vivo titration. 
Relationship  between  Skin  Sensitivity  and  Non-Precipitating  Antitoxin.-- 
Thirty subjects comprised the group whose sera were tested for antitoxic activ- 
ity both by rabbit skin test and by specific precipitation. Of the 16 who claimed 
no history of allergy, only 2 gave an immediate reaction to the Schick control 
toxoid prior to immunization. Following immunization, 3 subjects showed no 
precipitation whatever with toxin despite antitoxin titers of 20 to 80 units/cc. 
In 3 other cases there was only 0.5 to 1.3 #g. specifically precipitable nitrogen 
per unit while in the remaining 10 individuals, either the expected amount of 
precipitation was found (i.e. 2 to 2.5 #g. nitrogen per unit) or good precipitation 
was observed with amounts of toxin or toxoid equivalent to the rabbit titer. 
The 6  subjects whose sera showed in  vitro/in  vivo antitoxin discrepancies all 
had negative immediate skin reactions to toxoid before immunization. Follow- 
ing  immunization positive  reactions  occurred  in  5  of  them.  In  general  the 
severity of the immediate skin reaction to toxoid following immunization was 
correlated with the antitoxin titer and with the magnitude of the in vivo/in 
vitro discrepancy (see Table IV). 
Of 14 subjects who comprised the group claiming a personal or familial history 
of allergy, 12 showed skin sensitivity to Schick toxoid which was rated moder- 
ate to severe prior to immunization. Following immunization the severity of 
the wheal and erythema response  to  toxoid remained the  same or increased 
somewhat. Six  sera showed in  vivo/in  vitro  ratios of 1.8 or higher with only 
0.8 to 1.6 #g. specifically precipitable antitoxin nitrogen per unit instead of the 
expected 2 to 2.5/~g. nitrogen per unit. 
DISCUSSION 
Hypersensitivity of  the  immediate  type  following injection  of  materials 
used in the Schick test has received little attention in the past. When immedi- 
ate reactions of the wheal and erythema type have been noted it has generally 
been assumed that sensitivity was directed against constituents present in the 
original  culture  medium  or  against  the  peptone  used  as  stabilizing  agent. 
Nonetheless,  Neill  and  Fleming  (22)  demonstrated  that  certain  individuals 
showed the immediate type of hypersensitivity to diphtherial proteins and pro- 
duced evidence that in some subjects at least this hypersensitivity was specifi- 
cally directed against the toxin itself. 
In the present study a high proportion (30.5 per cent) of 131 medical students 
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intracutaneous injection of 0.008 Lf highly.purified diphtheria toxoid. The high 
incidence of skin sensitivity to purified diphtheria toxoid may, at first glance, 
appear surprising. However, it will be recalled that until recently it has been 
customary to dilute Schick materials in buffers containing various peptones as 
stabilizing agents. It was shown by Hooker (23) that a large percentage of young 
adults show skin sensitivity to the peptones present in Schick diluent and our 
own experience fully corroborates that of Hooker. Evidence of hypersensitivity 
specifically directed against diphtherial products would thus have been masked 
in most cases by reactions caused by the diluents used. The use of human serum 
albumin as stabilizing agent, as in the present study, obviates this difficulty. 
The incidence of immediate cutaneous reactions was twice as high in Schick- 
negative as  in  Schickopositive  subjects  and  reactions  were  more  intense  in 
members  of the  Schickonegative group  than in  those of the  Schick-positive 
group. It is of interest that 4  of the 6  Schick-positive subjects who showed 
immediate reactions proved Schick-negative on retest 1 month later, indicating 
the presence of some antitoxin at the time the first test was performed. Addi- 
tional evidence that the immediate type skin reactions observed in this study 
are caused by the specific diphtheria toxin or toxoid will be presented in the 
following paper. 
The relatively high incidence of hypersensitivity to diphtheria toxoid is in 
keeping with the findings of other workers who tested other materials. Grow 
and Herman  (24)  performed intracutaneous tests on a  group of 150 normal 
persons  using  thirteen  common  allergens  as  testing  substances.  Under  the 
conditions of their experiment, 83 or 55.5 per cent gave positive reactions to 
one or more of the allergens. 46 per cent gave reactions to horse dander alone. 
Somewhat similar results were obtained by Rackemann and Simon (25) and 
by Berger  (26). 
There was a  remarkable correlation between personal or familial history of 
allergy and the occurrence of immediate reactions to the Schick test. Thus of 
59 medical students who gave either a personal or familial history of hay-fever. 
or other allergic manifestations 35  (60 per cent) showed wheal and erythema 
reaction to the toxoid used as Schick control and only slight or no immediate 
reaction to the tuberculin test administered simultaneously or to the diluent 
used in the Schick test. Only 5 (7 per cent) of the 72 students claiming a com- 
pletely negative allergic history showed a  slight or moderate degree of skin 
sensitivity. 
Further investigation was concerned with the occurrence of non-precipitating 
antitoxin in the serum of hyperimmunized subjects and its association with 
the immediate skin reaction. In a previous paper (1)  studies on the precipitin 
reaction between diphtheria toxin and antitoxin in the serum of 12 apparently 
normal human subjects  were  reported.  It was shown that human antitoxic 
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antitoxin and the mean ratio of in vivo titer as determined by intracutaneous 
rabbit assay to in ~itro titer (quantitative precipitin) was 1.3. One or two anti- 
toxic sera were encountered in the earlier study  2 which showed unexplained 
discrepancies between in vivo and in vitro titers. Such atypical sera contained 
far less specifically precipitable antitoxin than expected. 
A relatively large proportion of the antitoxins examined during the present 
study  showed  such  discrepancies.  Moreover,  the  proportion  of  individuals 
showing discrepant in  vivo/in vitro ratios was no greater  among the  allergic 
group than among those who disclaimed all knowledge of familial or personal 
allergy. In fact, the 3 individuals who produced no precipitating antibody what- 
ever despite high titers of non-precipitating antitoxin, denied any history of 
personal or familial allergy. This is not particularly surprising in view of the 
findings of others  (27,  28)  that the development of allergy in patients under 
treatment with liver extract, insulin, and other materials cannot be predicted 
on the basis of the patient's past history. 
Although most subjects developed some degree of skin sensitivity following 
the booster dose of toxoid there was marked parallelism between the severity 
of the skin reactions observed and the presence of demonstrable amounts of 
non-precipitating antitoxin (see Table IV). Thus, of 12 individuals whose sera 
showed in vivo/in vitro ratios of 1.8 or greater, all but one showed +++  and 
++++  immediate skin reactions when tested subsequent to immunization. 
One subject with 20 units per cc. of non-precipitating antitoxin showed a -[-+ 
reaction. Of 7 individuals whose sera showed ratios ranging from 1.0 to  1.4, 
6  gave  immediate reactions  of only +  or  ++  intensity. One  subject  with 
10 units showed a +++  reaction. Additional confirmatory evidence was pro- 
vided by the behavior of the 10 hyperimmunized subjects who had no history 
of allergy and whose sera gave visible precipitates with toxoid despite a  rela- 
tively low antitoxin titer. None of these persons showed more than slight skin 
sensitivity (0 to +). 
A detailed comparison of the in vivo and in vitro properties of human pre- 
cipitating and non-precipitating antitoxin will be presented  in the following 
paper. 
SUMMARY 
Among a group of 131 young adults tested, there was a high degree of corre- 
lation between the  occurrence of immediate skin reactions of the wheal and 
erythema type produced by purified diphtheria toxoid and personal or familial 
history of allergy of the hay-fever type. 
Of 39  Schick-negative subjects who  received a  "booster" dose of purified 
diphtheria toxoid, 19 showed no immediate skin reactions before immunization. 
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The development of skin sensitivity in these subjects was associated with the 
production of non-precipitating circulating antitoxin. 
Three subjects produced 20 units or more antitoxin per cc. serum following 
immunization, without demonstrable precipitins.  Despite  the fact that none 
showed immediate skin reactions to Schick toxoid prior to immunization, all 
3 possessed a high degree of skin sensitivity to toxoid following immunization. 
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